Adipokines in gestational diabetes

Lancet Diabetes Endocrinol. 2014 Jun;2(6):488-99. doi: 10.1016/S2213-8587(13)70176-1. Epub 2013 Dec 30.

Abstract

Gestational diabetes is characterised by glucose intolerance with onset or first recognition during pregnancy. The disease shows facets of the metabolic syndrome including obesity, insulin resistance, and dyslipidaemia. Adipokines are a group of proteins secreted from adipocytes, which are dysregulated in obesity and contribute to metabolic and vascular complications. Recent studies have assessed the role of various adipokines including leptin, adiponectin, tumour necrosis factor α (TNFα), adipocyte fatty acid-binding protein (AFABP), retinol-binding protein 4 (RBP4), resistin, NAMPT, SERPINA12, chemerin, progranulin, FGF-21, TIMP1, LCN2, AZGP1, apelin (APLN), and omentin in gestational diabetes. This Review provides an overview of these key adipokines, their regulation in, and potential contribution to gestational diabetes. Based on the evidence so far, the adipokines adiponectin, leptin, TNFα, and AFABP seem to be the most probable candidates involved in the pathophysiology of gestational diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adipokines / blood
  • Adipokines / metabolism*
  • Adiponectin / metabolism
  • Blood Glucose / metabolism*
  • Diabetes, Gestational / blood
  • Diabetes, Gestational / metabolism*
  • Fatty Acid-Binding Proteins / metabolism
  • Female
  • Humans
  • Insulin Resistance
  • Leptin / metabolism
  • Pregnancy
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Adipokines
  • Adiponectin
  • Blood Glucose
  • FABP4 protein, human
  • Fatty Acid-Binding Proteins
  • Leptin
  • Tumor Necrosis Factor-alpha